DWORETZKY; Steven

Patent Applications and Registrations

Patent applications and USPTO patent grants for DWORETZKY; Steven.The latest application filed is for "compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils".

Company Profile

4.12.15

DWORETZKY; Steven - Jefferson Hills PA
Dworetzky; Steven - Pittsburgh PA
Dworetzky; Steven - Middlefield CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Treating Conditions Related To Elevated Levels Of Eosinophils And/or Basophils App 20210267949 - BOZIK; Michael E. ; et al.	2021-09-02
Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils Grant 11,026,928 - Bozik , et al. June 8, 2	2021-06-08
Compositions and methods for treating conditions related to increased eosinophils Grant 10,980,783 - Bozik , et al. April 20, 2	2021-04-20
Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils Grant 10,828,284 - Bozik , et al. November 10, 2	2020-11-10
Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders Grant 10,456,381 - Bozik , et al. Oc	2019-10-29
Compositions And Methods For Treating Conditions Related To Increased Eosinophils App 20190321339 - BOZIK; Michael E. ; et al.	2019-10-24
Compositions and methods for treating conditions related to increased eosinophils Grant 10,383,856 - Bozik , et al. A	2019-08-20
Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils Grant 10,383,857 - Bozik , et al. A	2019-08-20
Compositions and methods for treating chronic urticaria Grant 10,195,183 - Bozik , et al. Fe	2019-02-05
Compositions And Methods For Treating Plasma Cell Disorders And B-cell Prolymphocytic Disorders App 20190022070 - BOZIK; Michael E. ; et al.	2019-01-24
Compositions And Methods For Treating Conditions Related To Elevated Levels Of Eosinophils And/or Basophils App 20180271839 - BOZIK; Michael E. ; et al.	2018-09-27
Compositions And Methods For Treating Conditions Related To Elevated Levels Of Eosinophils And/or Basophils App 20180228777 - BOZIK; Michael E. ; et al.	2018-08-16
Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders Grant 10,028,940 - Bozik , et al. July 24, 2	2018-07-24
Compositions And Methods For Treating Chronic Urticaria App 20180015073 - BOZIK; Michael E. ; et al.	2018-01-18
Compositions And Methods For Treating Plasma Cell Disorders And B-cell Prolymphocytic Disorders App 20170281604 - BOZIK; Michael E. ; et al.	2017-10-05
Compositions and methods for treating chronic urticaria Grant 9,763,918 - Bozik , et al. September 19, 2	2017-09-19
Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders Grant 9,642,840 - Bozik , et al. May 9, 2	2017-05-09
Compositions And Methods For Treating Conditions Related To Increased Eosinophils App 20160354350 - BOZIK; Michael E. ; et al.	2016-12-08
Compositions and methods for treating conditions related to increased eosinophils Grant 9,468,630 - Bozik , et al. October 18, 2	2016-10-18
Compositions And Methods For Treating Chronic Urticaria App 20160193186 - Bozik; Michael E. ; et al.	2016-07-07
Compositions And Methods For Treating Plasma Cell Disorders And B-cell Prolymphocytic Disorders App 20160193187 - BOZIK; Michael E. ; et al.	2016-07-07
Compositions And Methods For Treating Conditions Related To Elevated Levels Of Eosinophils And/or Basophils App 20160158205 - BOZIK; Michael E. ; et al.	2016-06-09
Compositions And Methods For Treating Conditions Related To Increased Eosinophils App 20150018397 - BOZIK; Michael E. ; et al.	2015-01-15
Compounds And Methods Of Modulating Mitochondrial Bioenergetic Efficiency Through An Interaction With Atp Synthase (complex V) And Its Subunits App 20130273557 - Gribkoff; Valentin ; et al.	2013-10-17
DNA encoding rodent KCNQ2 potassium channel Grant 7,041,496 - Blanar , et al. May 9, 2	2006-05-09
KCNQ potassium channels and methods of modulating same App 20020168724 - Blanar, Michael A. ; et al.	2002-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.